Scientists found a way to restart cell division safely and reverse ageing in mice
Live Forever Club - 16-Jan-2025Treated mice lived longer, moved better, and remembered more
Join the club for FREE to access the whole archive and other member benefits.
Treated mice lived longer, moved better, and remembered more
Dysfunctional cells worsen ageing, but targeting them offers anti-ageing solutions
This could benefit cancer patients by reducing the effects of chemotherapy
This may revolutionise organ transplants and disease treatments
From Parkinson’s to diabetes, therapies transforming lives
New insights into how cells shape brain ageing and resilience
How reprogrammed cells from centenarians could revolutionize ageing and disease research
This new method could help more people with similar vision issues in the future
Toronto researchers reveal neural crest cells' hidden role in direct lineage transitions
Reprogrammed cells from healthy donors give hope to patients with severe corneal damage
Potential risks like DNA damage from space radiation require further study
Unlocking the secrets of longevity with induced pluripotent stem cells
Clock.bio secures funding to explore genetic pathways for enhancing healthspan
A successful retinal transplant in a monkey shows promise for treating vision loss
Mesenchymal stem cells may revolutionize healthcare by combating inflammation and ageing
A pioneering trial reveals the potential of reprogrammed stem cells to reverse type 1 diabetes
The startup leverages its TFome™ platform for rapid and efficient iPSC programming
This lab-grown blood could solve donor shortages and help with frequent transfusions
Cutting-edge AI and laser technology will scale production of personalized regenerative medicines
New stem cell breakthrough offers personalized cancer treatment with less rejection risk
Ancient genes in sea anemones offer insights into ageing and regeneration
75% of participants experienced clinical improvement in both pain and function
No severe issues came from the therapy itself, just the procedure or immunosuppression
New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
This opens up new possibilities for regenerative medicine and tissue repair